IXICO (PHYOF) Total Equity: $14.29 Mil (As of Mar. 2026)


PHYOF IXICO PLC PHYOF
42 GF Score
Price $0.07
GF Value $0.07
! 2 Warning Signs
View Full Analysis

What is IXICO Total Equity?

IXICO PHYOF -53.33% 42 Total Equity is $14.29 Mil as of Mar. 2026. GuruFocus rates PHYOF with a GF Score™ of 42/100 and a GF Value™ of $0.07. The stock has 2 warning signs investors should review.

IXICO's total equity for the quarter that ended in Mar. 2026 was $14.29 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

IXICO Total Equity Historical Data

* Premium members only.

The historical data trend for IXICO's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IXICO Total Equity Chart

IXICO Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.77 14.15 14.15 12.52 15.86

IXICO Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.76 12.52 15.88 15.86 14.29
PHYOF
42GF Score
IXICO PLC PHYOF
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IXICO Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

IXICO's Total Equity for the fiscal year that ended in Sep. 2025 is calculated as

Total Equity=Total Assets(Q: Sep. 2025 )-Total Liabilities(Q: Sep. 2025 )
=18.701-2.841
=15.86

IXICO's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=17.315-3.027
=14.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $14.29 Mil mean?
IXICO (PHYOF) has a Total Equity of $14.29 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for IXICO and its competitors.
Is IXICO's Total Equity too high?
IXICO's current Total Equity is $14.29 Mil. Overall, IXICO has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does IXICO's Total Equity compare to VRTX and REGN?
IXICO's Total Equity of $14.29 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for IXICO and its competitors. IXICO's current Total Equity is $14.29 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IXICO stock overvalued right now?
IXICO (PHYOF) has a current Total Equity of $14.29 Mil. The stock's GF Value™ is $0.07, compared to a current price of $0.07 — trading right at its estimated fair value. The current Total Equity is $14.29 Mil. IXICO's overall GF Score™ is 42/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For IXICO (PHYOF), the current Total Equity is $14.29 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IXICO (PHYOF) Overvalued in 2026?

Based on GuruFocus' analysis, IXICO stock appears to be undervalued. The current stock price of $0.07 is trading 0% below its estimated GF Value™ of $0.07.

Key valuation signals for PHYOF:

  • Total Equity: $14.29 Mil
  • GF Value™: $0.07 vs. price of $0.07 (0% below fair value)
  • GF Score™: 42/100 with 2 warning signs

No single metric tells the full story. See the PHYOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IXICO Business Description

Other Exchanges IXI:UK
Address 15 Long Lane, 4th Floor, Griffin Court, London, GBR, EC1A 9PN
IXICO PLC provides neuroscience imaging and biomarker analytics services, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring. It operates as an imaging contract research organization, supporting clinical trials for neurological disorders by processing and analyzing imaging data. Its platform is used to measure biomarkers associated with diseases such as Alzheimer's, Huntington's, and Parkinson's.
42GF Score

Get the complete analysis for PHYOF

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.07
Price
$0.07
GF Value